PET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide

Tudi K, Jie Z, Chen Z, et al.

Molecular pharmaceutics;23(11):5620-5629

Combined time-restricted feeding and resistance training enhance tirzepatide-induced improvements in adiposity and whole-body insulin sensitivity in female mice

Macêdo APA, da Conceição de Mattis LR, de Lima RD, et al.

The Journal of physiology, 2026

Continued CagriSema treatment preserves weight loss by reducing energy intake and maintaining energy expenditure in rats

Petersen LM, Knop FK, le Roux CW, et al.

Molecular metabolism, 2026;:102464

GLP-1 receptor activation attenuates chronic migraine-like behaviour: Sex-specific modulation of opioid- and endocannabinoid-related pathways

Sićović K, Nastić K, Dinić M, et al.

British journal of pharmacology, 2026

The GLP-1 receptor agonist semaglutide reduces alcohol consumption and anxiety-like behaviors during withdrawal in Marchigian Sardinian alcohol-preferring rats

Palmisano M, Mrizak H, Gonzalez AE, et al.

Neuropharmacology, 2026;:111240

Paracrine TMSB4X signaling from oligodendrocytes promotes diffuse glioma dissemination

Chai KM, Tsai CH, Lin MY, et al.

Oncogene, 2026

Semaglutide and Tirzepatide Suppress Hepatic Fatty Acid Uptake and Fatty Acid β-Oxidation in High-Fat Diet-Induced Obesity Mice

Patel D, Ewida H, Tareq S, et al.

Journal of proteome research;25(10):5418-5429

Butyrate enhances the obesity reduction effect of Semaglutide

Huang Y, Gu K, Li C, et al.

Neuroendocrinology, 2026;:1

Transient Adipose Inflammatory Remodeling during High-Dose Semaglutide-Induced Weight Loss and Regain

Seo M, Julietta V, Averia M, et al.

Endocrinology and metabolism (Seoul, Korea), 2026

Poly(vinyl alcohol) dissolving microneedles for transdermal semaglutide delivery and anti-obesity therapy in rats

Cheng X, Wang F, Liu H, et al.

International journal of pharmaceutics, 2026;:127576

Semaglutide Remodels the Gut Microbiome Beyond Its Appetite-Suppressing Action: Sex-Specific Gut-Brain Axis Implications

Byun S, Sotzen MR, Bento MT, et al.

Comprehensive physiology, 2026;16(5):e70286

Chronic Intermittent Hypoxia and MASLD in Obstructive Sleep Apnea: A Critical Appraisal of Mechanistic and Causal Evidence

Cebuc Simeanu GM, Dragne IG, Mitrea A, et al.

International journal of molecular sciences, 2026;27(20)

Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury

Koehler JA, Baggio LL, Cao X, et al.

Cell reports. Medicine, 2026;:103115

Mechanistic benchmarking of SNAC, DDM, and LLC reveals enhancer-dependent pathways for intestinal semaglutide delivery

Yuan B, Sui Y, Li H, et al.

Journal of controlled release : official journal of the Controlled Release Society, 2026;:115455

Pharmacy students’ knowledge and attitudes regarding GLP-1 receptor agonist adverse effects in obesity management: a cross-sectional study

Khojah AA, Gazzaz MJ, Aldurdunji MM, et al.

The Libyan journal of medicine, 2026;21(1):2749899

Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile

Keskin U, Altın E, Özatik FY, et al.

Journal of molecular histology, 2026;57(6)

The Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction-Associated Steatohepatitis-A Narrative Review with a Translational Focus

Ard JD, Almandoz JP

Obesity reviews : an official journal of the International Association for the Study of Obesity, 2026;:e70228

Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms

Barseghyan L, Munir I, Chrysafide S, et al.

Journal of clinical medicine, 2026;15(20)

Development and validation of qualitative methods for the detection of GLP-1 receptor agonists in serum and dried blood spots by LC-HRMS/MS for doping control purposes

Borschel L, Thomas A, Studer D, et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2026;1285:125326

Correction to: Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology;28(10)